Search
FibroGen Ord Shs
KYNBAdd to Watchlist
7.250USD
-0.030-0.41%
Close 09-23 16:00（ET）
29.36MMarket Cap
0.18P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.41%
5 Days
-4.73%
1 Month
-3.59%
6 Months
+2.69%
Year to Date
-17.43%
1 Year
-39.43%
Key Figures
7.090Open
7.300High
1.10KVolume
0.18P/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
7.280Prev. Close
7.030Low
7.93KTurnover
LossP/E Static
-0.97P/B
0.00%Div Yield TTM
-41.17%ROA
12.58052wk High
0.03Volume Ratio
-47.58MNet Profit
4.05MShares
40.4711EPS TTM
1.03Beta
--ROE
6.32052wk Low
3.98%Amplitude
-81.45%Gross Margin
29.36MMarket Cap
0.05Reward/Risk
3.28%Risk Rate
Analyst Rating
FibroGen Ord Shs Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
FibroGen Ord Shs Latest Earnings Call Transcripts
KYNB Q2 2026 Earnings Call: $95.7M Liquidity and Q4 Clinical Catalysts
KYNB’s Q2 2026 earnings call covered $95.7 million in liquidity, a runway into 2028 and Q4 catalysts for FG-3246 and roxadustat.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
2.96/-3.18
Revenue / Forecast
-1.47M/2.01M
Ownership
| Shareholders | Proportion |
|---|---|
| Armistice Capital LLC | 9.88% |
| Vanguard Capital Management, LLC | 3.87% |
| Acadian Asset Management LLC | 2.61% |
| BlackRock Institutional Trust Company, N.A. | 2.08% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 13.42% |
| Investment Advisor | 9.24% |
| Investment Advisor/Hedge Fund | 5.64% |
| Individual Investor | 1.96% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%Popular Instruments
51390.700
-99.300 (-0.19%)
30371.100
-106.800 (-0.35%)
7684.700
-22.300 (-0.29%)
14290.000
-132.000 (-0.92%)
65650.000
-479.000 (-0.72%)
6271.000
-19.000 (-0.30%)
91.123
-1.367 (-1.48%)
337.020
-2.730 (-0.80%)
225.510
-3.360 (-1.47%)
4283.900
-2.340 (-0.06%)
FAQs
What is the current price of FibroGen Ord Shs (KYNB)?
The current price of FibroGen Ord Shs (KYNB) is 7.25.
What is the symbol of FibroGen Ord Shs?
The ticker symbol of FibroGen Ord Shs is KYNB.
What is the 52-week high of FibroGen Ord Shs?
The 52-week high of FibroGen Ord Shs is 12.58.
What is the 52-week low of FibroGen Ord Shs?
The 52-week low of FibroGen Ord Shs is 6.32.
What is the market capitalization of FibroGen Ord Shs?
The market capitalization of FibroGen Ord Shs is 29.36M.
Is FibroGen Ord Shs (KYNB) currently rated as Buy, Hold, or Sell?
According to analysts, FibroGen Ord Shs (KYNB) has an overall rating of Buy, with a price target of 39.67.
What is the Earnings Per Share (EPS TTM) of FibroGen Ord Shs (KYNB)?
The Earnings Per Share (EPS TTM) of FibroGen Ord Shs (KYNB) is 40.47.